These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 23270554)

  • 21. Endless Journey of Adenosine Signaling in Cardioprotective Mechanism of Conditioning Techniques: Clinical Evidence.
    Kumar K; Singh N; Yadav HN; Maslov L; Jaggi AS
    Curr Cardiol Rev; 2023; 19(6):56-71. PubMed ID: 37309766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of gasotransmitters NO, H2S and CO in myocardial ischaemia/reperfusion injury and cardioprotection by preconditioning, postconditioning and remote conditioning.
    Andreadou I; Iliodromitis EK; Rassaf T; Schulz R; Papapetropoulos A; Ferdinandy P
    Br J Pharmacol; 2015 Mar; 172(6):1587-606. PubMed ID: 24923364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardioprotection: chances and challenges of its translation to the clinic.
    Heusch G
    Lancet; 2013 Jan; 381(9861):166-75. PubMed ID: 23095318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remote ischemic conditioning: from bench to bedside.
    Lim SY; Hausenloy DJ
    Front Physiol; 2012; 3():27. PubMed ID: 22363297
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protective cardiac conditioning by an atypical cytokine.
    Bernhagen J
    Clin Sci (Lond); 2019 Apr; 133(8):933-937. PubMed ID: 31000564
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic conditioning protects the uremic heart in a rodent model of myocardial infarction.
    Byrne CJ; McCafferty K; Kieswich J; Harwood S; Andrikopoulos P; Raftery M; Thiemermann C; Yaqoob MM
    Circulation; 2012 Mar; 125(10):1256-65. PubMed ID: 22319109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification.
    Varga ZV; Giricz Z; Bencsik P; Madonna R; Gyongyosi M; Schulz R; Mayr M; Thum T; Puskas LG; Ferdinandy P
    Curr Drug Targets; 2015; 16(8):904-11. PubMed ID: 25915487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of risk factors, comorbidities, and comedications with ischemia/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning.
    Ferdinandy P; Hausenloy DJ; Heusch G; Baxter GF; Schulz R
    Pharmacol Rev; 2014 Oct; 66(4):1142-74. PubMed ID: 25261534
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology.
    Madonna R; Cadeddu C; Deidda M; Giricz Z; Madeddu C; Mele D; Monte I; Novo G; Pagliaro P; Pepe A; Spallarossa P; Tocchetti CG; Varga ZV; Zito C; Geng YJ; Mercuro G; Ferdinandy P
    Int J Cardiol; 2015 Jul; 191():203-10. PubMed ID: 25974196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery.
    Bousselmi R; Lebbi MA; Ferjani M
    J Saudi Heart Assoc; 2014 Apr; 26(2):93-100. PubMed ID: 24719539
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preconditioning and postconditioning: united at reperfusion.
    Hausenloy DJ; Yellon DM
    Pharmacol Ther; 2007 Nov; 116(2):173-91. PubMed ID: 17681609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel therapeutic strategies for cardioprotection.
    Sluijter JP; Condorelli G; Davidson SM; Engel FB; Ferdinandy P; Hausenloy DJ; Lecour S; Madonna R; Ovize M; Ruiz-Meana M; Schulz R; Van Laake LW;
    Pharmacol Ther; 2014 Oct; 144(1):60-70. PubMed ID: 24837132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiac innervation in acute myocardial ischaemia/reperfusion injury and cardioprotection.
    Hausenloy DJ; Bøtker HE; Ferdinandy P; Heusch G; Ng GA; Redington A; Garcia-Dorado D
    Cardiovasc Res; 2019 Jun; 115(7):1167-1177. PubMed ID: 30796814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.
    Hausenloy DJ; Baxter G; Bell R; Bøtker HE; Davidson SM; Downey J; Heusch G; Kitakaze M; Lecour S; Mentzer R; Mocanu MM; Ovize M; Schulz R; Shannon R; Walker M; Walkinshaw G; Yellon DM
    Basic Res Cardiol; 2010 Nov; 105(6):677-86. PubMed ID: 20865418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ischemic preconditioning produces more powerful anti-inflammatory and cardioprotective effects than limb remote ischemic postconditioning in rats with myocardial ischemia-reperfusion injury.
    Zhang JQ; Wang Q; Xue FS; Li RP; Cheng Y; Cui XL; Liao X; Meng FM
    Chin Med J (Engl); 2013 Oct; 126(20):3949-55. PubMed ID: 24157164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacological Conditioning of the Heart: An Update on Experimental Developments and Clinical Implications.
    Roth S; Torregroza C; Feige K; Preckel B; Hollmann MW; Weber NC; Huhn R
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33802308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physiology and pharmacology of myocardial preconditioning and postconditioning.
    Huffmyer J; Raphael J
    Semin Cardiothorac Vasc Anesth; 2009 Mar; 13(1):5-18. PubMed ID: 19329471
    [TBL] [Abstract][Full Text] [Related]  

  • 40. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.